Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of the Decrease of Length of Stereotactic Body Radiation Therapy in the Treatment of Stage IA - IB Non Small Cell Lung Cancer (T1N0M0 or T2aN0M0)

NCT03921957 is registered in ClinicalTrials.gov with Centre Paul Strauss as lead sponsor.

NCT NCT03921957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03921957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of the Decrease of Length of Stereotactic Body Radiation Therapy in the Treatment of Stage IA - IB Non Small Cell Lung Cancer (T1N0M0 or T2aN0M0)
Lead sponsor
Centre Paul Strauss
Phase
Not applicable
Overall status
Unknown status
Start date
November 24, 2015
Completion date
December 31, 2021
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia - ib non small cell lung cancer